{"id":"https://openalex.org/A5117935490","orcid":"https://orcid.org/0009-0000-9635-8960","observed_orcids":["https://orcid.org/0009-0000-9635-8960"],"display_name":"Valeria A. Kushner","raw_author_names":["V. A. Kushner","Valeria A. Kushner","\u041a\u0443\u0448\u043d\u0435\u0440 \u0412. \u0410."],"full_name":"Valeria A. Kushner","works_count":3,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117935490","orcid":"https://orcid.org/0009-0000-9635-8960","observed_orcids":["https://orcid.org/0009-0000-9635-8960"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210164656","ror":"https://ror.org/05erbjx97","display_name":"V.I. Vernadsky Crimean Federal University","country_code":"UA","type":"education","lineage":["https://openalex.org/I4210164656"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210164656","ror":"https://ror.org/05erbjx97","display_name":"V.I. Vernadsky Crimean Federal University","country_code":"UA","type":"education","lineage":["https://openalex.org/I4210164656"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":7.7e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":6.5e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","value":6.1e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","value":1.4e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.7598999738693237},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.7305999994277954},{"id":"8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","score":0.5841000080108643},{"id":"105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","score":0.3312000036239624},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.27410000562667847}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":0}],"display_name_alternatives":["V. A. Kushner","Valeria A. Kushner","\u041a\u0443\u0448\u043d\u0435\u0440 \u0412. \u0410."],"block_key":"v kushner","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117935490","updated_date":"2026-10-12T12:34:37","created_date":"2025-10-04T00:00:00"}